Hamilton Thorne (TSX:HTL) Institutional Ownership : 7.75% (As of Jun. 07, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hamilton Thorne's institutional ownership is 7.75%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hamilton Thorne's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hamilton Thorne's Float Percentage Of Total Shares Outstanding is 0.00%.

Hamilton Thorne Institutional Ownership Historical Data

The historical data trend for Hamilton Thorne's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Institutional Ownership Chart

Hamilton Thorne Historical Data

The historical data trend for Hamilton Thorne can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	8.29	8.31	7.74	7.31	7.56	7.86	7.95	7.81	7.78	7.75

Hamilton Thorne Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Hamilton Thorne (TSX:HTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

HTLZF:USA 0ZM:Germany

Address

100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915

Website

https://www.hamiltonthorne.ltd

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.

Executives

Robert J Potter

Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines